Tag: Radio-Isotope Therapy of America (RITA) Foundation
![ebrahim s delpassand md facnm](https://www.carcinoid.org/wp-content/uploads/2010/08/ebrahim-s-delpassand-md-facnm.jpg)
FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
August 24, 2010
For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…
READ MORE